Krystal Biotech Inc (KRYS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | KRYS | CYTK | NUVL | ||
| Company | Krystal Biotech Inc | Cytokinetics | Nuvalent Inc Cl A | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 309.03 | 76.09 | 110.51 | ||
| High | 309.03 | 76.48 | 110.53 | ||
| Low | 298.00 | 73.18 | 92.49 | ||
| Latest | 298.10 | 73.68 | 93.01 | ||
| Change | -10.93 | -3.08 | -17.38 | ||
| % Change | -3.54% | -4.01% | -15.74% | ||
| Volume | 263,100 | 1,659,800 | 2,945,000 | ||
| 20-Day Average Volume | 309,405 | 3,578,735 | 679,225 | ||
| Previous Close | 309.03 | 76.76 | 110.39 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 301.94 | 75.82 | 103.33 | ||
| 20-Day Raw Stochastic | 68.33% | 62.09% | 2.65% | ||
| 20-Day Relative Strength | 54.51 | 53.34 | 39.41 | ||
| Weighted Alpha | +110.49 | +72.55 | +9.87 | ||
| Today's Opinion | 88% Buy | 88% Buy | 8% Buy | ||
| Previous Opinion | 100% Buy | 100% Buy | 100% Buy | ||
| Last Month's Opinion | 72% Buy | 72% Buy | 16% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.45% since 05/22/26 | -4.24% since 05/22/26 | -8.92% since 05/22/26 | ||
| Low | 298.00 on 06/01/26 | 73.18 on 06/01/26 | 92.49 on 06/01/26 | ||
| High | 315.58 on 05/29/26 | 78.85 on 05/28/26 | 112.09 on 05/29/26 | ||
| 1-Month | |||||
| %Chg | +12.05% since 05/01/26 | +16.31% since 05/01/26 | -6.09% since 05/01/26 | ||
| Low | 251.97 on 05/04/26 | 63.00 on 05/04/26 | 92.49 on 06/01/26 | ||
| High | 319.48 on 05/14/26 | 80.20 on 05/05/26 | 112.09 on 05/29/26 | ||
| 3-Month | |||||
| %Chg | +8.15% since 02/27/26 | +18.42% since 02/27/26 | -8.77% since 02/27/26 | ||
| Low | 242.00 on 03/31/26 | 58.43 on 03/13/26 | 92.49 on 06/01/26 | ||
| High | 319.48 on 05/14/26 | 80.20 on 05/05/26 | 112.09 on 05/29/26 | ||
| 6-Month | |||||
| %Chg | +38.58% since 12/01/25 | +11.55% since 12/01/25 | -12.60% since 12/01/25 | ||
| Low | 212.75 on 12/02/25 | 58.43 on 03/13/26 | 92.49 on 06/01/26 | ||
| High | 319.48 on 05/14/26 | 80.20 on 05/05/26 | 113.01 on 01/22/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 9,110,201 | 9,551,477 | 8,720,589 | ||
| Shares Outstanding, K | 29,480 | 124,433 | 78,998 | ||
| Annual Sales | 389,130,000 | 88,040,000 | 0 | ||
| Annual Net Income | 204,830,000 | -784,960,000 | -425,380,000 | ||
| Last Quarter Sales | 116,360,000 | 19,360,000 | 0 | ||
| Last Quarter Net Income | 55,930,000 | -206,030,000 | -109,280,000 | ||
| 60-Month Beta | 0.50 | 0.38 | 1.15 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 1.83 on 05/04/26 | -1.67 on 05/05/26 | -1.39 on 05/07/26 | ||
| Earnings Date | 08/03/26 | 08/06/26 | 08/06/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 41.48 | 0.00 | 0.00 | ||